Workflow
机器人大讲堂
icon
Search documents
工业机器人迎来“二次复兴”
机器人大讲堂· 2026-01-26 10:17
2026 年 1 月 23 日 ,世界顶级投行盛博 ( Bernstein ) 的一份报告在工业自动化领域投下一枚深水炸弹: 工业机器人行业正迎来 " 第二次复兴 " 。 报告预测,未来十年全球工业机器人出货量年复合增长率将高达 12% 。全球工业机器人正在经历从 " 灵活 " 到 " 智能 " 的进化 , 而背后的推手 已经 不 再仅仅 是更 强劲 的电机,而是一颗会思考的 " 大脑 " 。 0 1 物理 AI 的四层生态:不只是 " 更聪明 " 想象一下这个画面: 2020 年之前的汽车工厂里,一排排橙黄色的机械臂以完美的同步性进行点焊、喷涂, 每一个动作都像被编好程序的舞蹈 ,精准却冰冷。 但 它们无法应对一颗意外滚落的螺丝,更不会处理柔软的线束 , 直到物理 AI , 或者说具身智能技术 的出 现,改变了这一切。 盛博报告清晰勾勒出行业发展的三级跳 。 从 1980 年代开始的固定路径阶段 ,机器人只能完成预设的单一动作 ,应用场景局限于汽车点焊、车身喷 涂、固定点位拾取等标准化操作 ; 到 2020 年代开启的灵活路径规划阶段 ,机器人能实时调整路径,应对变化的环境 , 解锁 了 机床上下料、 码垛 ...
埃斯顿连续八年保持中国机器人市场第一
机器人大讲堂· 2026-01-26 10:17
Core Insights - Estun Robotics continues to lead the Chinese market in 2025 with a market share of 10.6%, achieving a year-on-year shipment growth of 25%, contributing to a domestic market share of over 56% in industrial robots [1] - Chinese autonomous robot brands, represented by Estun, are officially leading the market into a new development phase [2] Group 1: High-Quality Growth - In 2025, AI and robotics technology are increasingly integrated, with Estun achieving both quantity and quality growth, moving out of industry competition and back to a high-quality growth path [3] - The Chinese robot market is stabilizing and recovering in price, with several manufacturers, including Estun, announcing price adjustments starting in the second half of 2025, indicating a return to healthy competition [3] - Estun's focus on vertical industry solutions has led to significant breakthroughs in the automotive sector, with applications in automotive parts and assembly, gaining traction with leading companies like BYD and Seres [3] Group 2: Product Upgrades and AI Integration - Estun has maintained its position as the top domestic robot brand for eight consecutive years, with its collaborative robot brand, Cozmo, experiencing over 270% shipment growth, making it the fastest-growing collaborative robot brand [6] - The company has developed a comprehensive technology stack, including automation components, industrial robots, collaborative robots, and AI-driven intelligent robots [6] - The launch of the new iER.OS operating system and the RoboBase platform marks a significant advancement in industrial intelligent applications, enhancing cross-platform development capabilities and real-time control [9] Group 3: International Expansion - Estun is entering an accelerated phase of international expansion in 2026, becoming the first Chinese robot brand with a full range of functional safety certification [10] - The company is focusing on building core benchmark application scenarios and partner ecosystems in various industries across Europe, ASEAN, and South America [10] - Estun is establishing a global production and supply system, with the completion of a factory in Poland and a network of 12 production and application experience centers, alongside 75 service points [15]
2026或迎具身智能“觉醒元年”,这场全球具身智能高地盛会启动招商!
机器人大讲堂· 2026-01-26 04:03
2025 年底, 140 余家 头部团队发布 了 330 款新一 代 人形机器人 ,在持续工作稳定性、复杂场景适应 性、多任务泛化能力等关键指标上,首次逼近了商业应用的及格线。特别是基于具身智能 VLA 大模型, 部分 机器人真正具备了观察 - 思考 - 行动的闭环能力。 产业生态完成了关键拼图。 以往制约产业化的三大瓶颈 , 核心部件成本、软件开发生态、验证标准 , 在 202 5 年均迎来突破性进展。国产高扭矩密度伺服电机的成本较三年前 已经 下降 50 % ;鸿蒙 M-Robots OS 、灵渠 OS 、 OpenWBT 等操作系统开源 , 实现了对具身智能模型的原生支持;由工信部牵头 的 人形 机器人标准化技术委员会 建立, 为2026年的规模化量产扫清了标准障碍。 2026 年, 我们 可能不再惊讶于一个 机器人出现 在工厂、 商场、舞台和大街, 因为这一切,正在成为常 态。 2026 年的 具身智能与 人形机器人产业,正站在一个历史性的交汇点上 , 技术、产业与资本的三重浪 潮首次实现同频共振, 有望 推动行业跨越落地的死亡谷。 如何看待 2026 年的具身智能与人形机器人产业?研究界、产业界、投 ...
马斯克喊出25万亿估值!Optimus Gen 3必须救活特斯拉!
机器人大讲堂· 2026-01-25 04:03
Group 1 - The core viewpoint is that Tesla's future success may hinge on the mass production of the Optimus humanoid robot, potentially overshadowing its automotive legacy [1][3][4] - Elon Musk supports this vision, suggesting that the robot business could push Tesla's valuation beyond $25 trillion, surpassing the current automotive segment [3][4] - Tesla's strategic shift towards Optimus is a response to declining automotive sales, with 2025 showing a significant drop in global deliveries and profits [7][8] Group 2 - In 2025, Tesla delivered 1.636 million vehicles, an 8.6% year-over-year decline, marking a critical loss of market position to BYD [8] - The European market has been particularly hard hit, with sales in countries like Germany and Sweden dropping over 50% [8] - Tesla's Q3 2025 revenue was $28.1 billion, with a net profit of $1.373 billion, down 37% year-over-year, indicating severe profitability challenges [8][10] Group 3 - The Optimus project, initiated in 2021, is set to unveil its third-generation model, Gen3, in early 2026, which is seen as a pivotal product for Tesla's transformation [11][14] - Optimus aims to serve various sectors, including industrial, domestic, healthcare, and space exploration, leveraging Tesla's existing technology [13][14] - The core competitive advantages of Optimus include technology reuse from Tesla's automotive business, cost control, and integrated hardware-software solutions [14] Group 4 - Despite ambitious goals, the commercial viability of Optimus faces significant hurdles, including production delays and technological challenges [17][21] - In 2025, Tesla's target of producing 5,000 units of Optimus was not met, with actual output in the hundreds, far below initial expectations [17] - The complexity of humanoid robotics, including AI decision-making and environmental perception, remains a barrier to achieving autonomous operation [17][21] Group 5 - Tesla's automotive business remains the primary revenue source, with Q3 2025 revenue entirely derived from this segment, raising concerns about the sustainability of its strategy [22][24] - The competitive landscape in the electric vehicle market is intensifying, with rivals like BYD rapidly advancing, which could jeopardize Tesla's market share if resources are diverted from automotive development [24] - Cash flow pressures are exacerbating the risks of Tesla's strategic gamble on Optimus, with significant capital required for its development amidst declining automotive revenues [25][27] Group 6 - Musk's history of overpromising on product timelines has led to skepticism regarding the ambitious targets for Optimus, including a $25 trillion valuation and the delivery of 1 billion units by 2030 [27][28] - The upcoming release of Optimus Gen3 in mid-2026 is viewed as a critical juncture that will influence market confidence in Tesla's future [28]
六维力传感器行业终将去伪存真
机器人大讲堂· 2026-01-25 04:03
Core Viewpoint - In 2025, the six-dimensional force sensor sector in China experienced a capital frenzy, with total financing reaching several hundred million RMB, primarily in early-stage rounds. Many startups claimed to be "first" in various aspects, but the actual market landscape is more complex than presented in promotional materials [1][5]. Group 1: Market Dynamics - The global humanoid robot industry is expected to see over 20,000 units sold in 2025, with China contributing over 80% of this market share. However, actual factory installations are only around 2,000 units, indicating that the industry is still in early production stages [2]. - The market for six-dimensional force sensors remains small and undeveloped, with most humanoid robot projects only validating sensors in limited areas, such as feet or wrists, rather than achieving standardization or bulk procurement [4]. Group 2: Investment Trends - Many companies in the sector are leveraging "leading" claims to attract attention and funding, often based on specific parameters achieved in controlled environments rather than practical applications [5][6]. - Investors are adopting a "broad net" strategy, focusing on the overall sector rather than individual companies, as the market is still fragmented and uncertain [8]. Group 3: Production and Cost Challenges - The primary path to cost reduction in the industry is through scaling production, creating a cyclical dilemma where increased robot deployment is needed to lower sensor costs, but high sensor costs hinder robot production [9]. - Most companies are currently in a transitional phase from prototype validation to small-scale production, making it difficult for sensor manufacturers to secure stable, large-volume orders [8][9]. Group 4: Future Outlook - By 2030, the annual shipment of six-dimensional force sensors is expected to exceed one million units, with the market potentially reaching a scale of billions. Current production capacity is seen as a strategic asset for future competition [12]. - The core challenge in manufacturing six-dimensional force sensors lies in "decoupling" complex force signals into independent components, which remains a significant technical hurdle for many domestic companies compared to international brands [13][14]. Group 5: Industry Evolution - As the humanoid robot industry matures, the focus will shift from mere funding and market visibility to actual product performance, delivery capabilities, and deep customer relationships [16][17]. - The first phase of the sensor competition is concluding, with the next phase emphasizing tangible product quality and reliability over financial metrics [17].
5分钟完成肺结节手术!珠海首例机器人穿刺手术背后,藏着一位“AI主刀”
机器人大讲堂· 2026-01-25 00:00
近日,在北京理工大学附属医院(珠海市人民医院)的手术室进行了一场特殊的手术。 手术台上是一位82岁高龄的患者,他左上肺有一个19*14mm的混合性结节,考虑为早期肺癌。由于年龄大 且曾有右肺癌切除史, 传统外科手术风险极高。 ▍技术内核,机器人强在何处? "软组织穿刺的最大难题,是呼吸导致的靶点移位。"北京理工大学前沿交叉学域副主任、医学工程学院院 长,项目首席科学家段星光教授解释道,针对手术临床难题,该机器人实现两大关键突破。 第一大突破是呼吸跟踪与动态补偿技术。 肺部结节会随着呼吸上下移动,幅度可达数厘米。团队研发的机器 人系统能实时感知这种移动,并指挥机械臂同步调整,确保针尖始终锁定目标。 然而,这次手术仅用时5分钟。在"真健康穿刺手术机器人"精准操控下,一支消融针一次性直达病灶核心,术 后影像显示病灶被完全覆盖。 ▍临床困境,高龄患者的治疗难题 这位患者的情况在胸外科并不少见:高龄、肺部手术史、新发肺结节。传统治疗方案面临两难——开胸手术创 伤大、恢复慢,对高龄患者风险极高;而常规的穿刺消融又严重依赖医生经验。 "混合性结节位置刁钻,患者呼吸会导致靶点移动,就像试图击中一个微微晃动的小靶心。"参与手术 ...
宇树澄清!2025年人形机器人出货量第一
机器人大讲堂· 2026-01-24 09:50
1月22日晚,宇树发布了一份关于2025年销量数据的澄清。宇树称,过去一个月,网上流传着很多关于宇树 2025年出货数量的不实信息。宇树此前从未对外告知过2025年的销售数据。 宇树表示,2025年人形机器人实际出货量超5500台(指实际出售发货给终端客户的数量,并非订单数量,订 单数量更高),2025年本体量产下线超6500台。上述均为宇树纯人形机器人的数量,不含双臂轮式等其他机 器人产品。 目前各种机器人形态多样,建议大家请勿把不同类型的机器人数量,直接合并在一起对比。 如需咨询企业合作事宜,欢迎联系机器人大讲堂-客服(19560423866,手机与微信同号)进行对接。 工业机器人企业 埃斯顿自动化 | 埃夫特机器人 | 法奥机器人 | 越疆机器人 | 节卡机器人 | 松灵机器人 | 珞石机器人 | 盈连 科技 | 集萃智造 | 优傲机器人 | CGXi长广溪智造 | 阿童木机器人 | 极智嘉 | 海康机器人 服务与特种机器人企业 亿嘉和 | 晶品特装 | 七腾机器人 | 史河机器人 | 九号机器人 | 普渡机器人 | 小笨智能 | 机器姬 | 施罗 德机器人 医疗机器人企业 元化智能 | 天智航 | 思 ...
灵心巧手、强脑科技、傲意科技、因克斯、戴盟机器人……灵巧手核心企业优势解析
机器人大讲堂· 2026-01-24 04:03
2025年末,具身智能踏入消费级产品的上市期。随着 面向个人与极客的四足及小型人形机器人开始上市销售 ,海量真实世界数据 将 推动其运动控制与决策中枢进入井喷式发展。与此同时, 小鹏、众擎 等 厂商在全尺寸人形机器人上取得的运动能力突破 , 可 以预见,机器人产业正迈入一个能力全面升级的关键时期。 当机器人的 "大脑"(大模型)与"四肢"(移动能力)愈发强大,价值实现的"最后一 厘米 "便落在了 灵巧操作 上。一双灵巧的手, 是机器人从被动 "观察者"蜕变为主动"劳动者"的关键, 是将数字智能转化为物理功用、并最终定义其价值上限的终极执行器。 这场围绕 "指尖革命"的博弈,已催生出繁荣的国内产业生态,涌现出 灵心巧手、强脑科技、傲意科技、因克斯、戴盟机器人、帕 西尼、灵巧智能、月泉仿生、源升智能、雷赛智能、舞肌科技、果力智能 等一批核心 企业 。 数据来源:公开资料信源,创业邦研究中心整理 在机器人 各 形态与尺寸同步发展的当下,对灵巧手的需求 将 呈现出前所未有的多样化,而这些玩家正是在 "性能-成本-可靠性" 的三角关系中, 围绕几种不同的技术路径展开探索,以精准适配不同的市场需求: 腱绳驱动( Tend ...
全球首例!港医疗团队借深圳锟铻®机器人“塔积木” 重建复杂髋关节
机器人大讲堂· 2026-01-24 04:03
Core Viewpoint - The article highlights the successful implementation of the world's first robot-assisted dual Augment (Footing) hip acetabulum repair total hip replacement surgery at the Hong Kong Aesthetic Hospital, showcasing a significant breakthrough in robotic-assisted orthopedic surgery for complex joint reconstruction [1][3]. Group 1: Surgical Innovation - The surgery was performed on an elderly patient suffering from severe hip joint pain and functional impairment, with imaging revealing rare dual-region bone defects in the acetabulum [3]. - Traditional surgical methods were inadequate for addressing both prosthetic stability and anatomical restoration, prompting the surgical team to innovate a customized "Footing prosthesis" using two Augment modules [3]. - The use of the Kuan robot enabled precise sub-millimeter 3D reconstruction, intelligent planning, and real-time navigation, allowing for a tailored solution that significantly improved bone coverage and restored the joint's rotational center to its physiological position [3][5]. Group 2: Technological Impact - The successful surgery exemplifies the perfect combination of advanced robotic technology and innovative clinical thinking, providing unprecedented certainty and capability in complex reconstruction surgeries [5]. - The Kuan robot, approved by the National Medical Products Administration (NMPA), is the world's first five-in-one orthopedic surgical robot, capable of addressing multiple indications including total knee, total hip, unicompartmental, spinal, and trauma surgeries [5]. - This milestone not only opens new treatment pathways for patients with complex hip joint diseases but also highlights the hospital's leading capabilities in integrating cutting-edge medical technology to enhance the treatment of difficult cases [5].
专家预判26年人形机器人进入死亡淘汰赛谁能穿越行业出清?
机器人大讲堂· 2026-01-24 04:03
2025年的人形机器人赛道,热度达到了前所未有的高度。春晚舞台上的灵动舞姿、机器人马拉松的速度角 逐、四位数价格的亲民产品亮相,让曾经停留在实验室的人形机器人加速走进公众视野。 资本的狂热更是推波助澜,据新战略移动机器人产业研究所统计, 2025年行业融资事件高达190起,总规模 突破270亿元人民币,中国境内的人形机器人企业数量已超100家,仿佛一场产业爆发近在眼前。 然而,喧嚣之下,行业 当中也出现了明显的分化迹象, 经过近三年 的产业飞速发展,人形机器人企业已出现 明显的分化现象,头部 手握亿元级订单筹备上市,尾部企业却深陷 "融资停滞、无产品落地"的困境。 无独有偶,在 2026年初,瑞银证券、智源研究院等机构纷纷发出预警,认为行业将迎来关键的 "出清期",缺 乏核心竞争力的企业将加速被市场淘汰。而深耕该领域二十余年的清华大学自动化系教授赵明国,在1月接受 媒体采访时也给出了精准预判:"2026 年也许会是应用场景的筛选年,人形机器人淘汰赛即将来临,只有深 扎场景、倾听市场的反馈才能活下去。" ▍ 2026年人形机器人产业将呈现更明显的马太效应 中国人形机器人行业的 "百团大战",正加速进入终局前的分 ...